The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators

An estimated 6.5 million Americans aged 65 years or older have Alzheimer’s disease (AD), which will grow to 13.8 million Americans by 2060. Despite the growing burden of dementia, no fundamental change in drug development for AD has been seen in > 20 years. Currently approved drugs for AD produce...

Descripción completa

Detalles Bibliográficos
Autores principales: Moebius, Hans J., Church, Kevin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041442/
https://www.ncbi.nlm.nih.gov/pubmed/36683507
http://dx.doi.org/10.3233/JAD-220871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041442/
https://www.ncbi.nlm.nih.gov/pubmed/36683507
http://dx.doi.org/10.3233/JAD-220871

Ejemplares similares